COVID-19阳性患者下肢深静脉血栓超声评估:检查阳性率及与D-二聚体水平的关系
本研究为回顾性病例对照研究,按年龄、性别和种族1:2匹配COVID-19阳性患者与阴性对照,比较下肢深静脉血栓超声阳性率及实验室指标差异。结论不支持将D-二聚体作为是否需要超声评估的替代指标。
要点
- COVID-19阳性与阴性患者下肢DVT超声阳性率无显著差异,不应仅凭COVID-19阳性即提高DVT验前概率。
- COVID-19患者无论有无DVT,D-二聚体均可显著升高,不能以D-二聚体水平决定是否行超声检查。
- 对COVID-19患者评估DVT时,应结合临床情况独立判断超声指征,而非依赖实验室替代指标。
核心结论
- COVID-19阳性与阴性患者下肢深静脉血栓超声检查阳性率无统计学显著差异。
- COVID-19患者中有无DVT者的D-二聚体水平无显著差异,不支持以D-二聚体作为超声评估的替代决策指标。
研究设计与样本
- 回顾性病例对照研究,按年龄、性别、种族1:2匹配COVID-19阳性病例与阴性对照。
- 评估的实验室指标包括血清D-二聚体、纤维蛋白原、凝血酶原时间、国际标准化比值和C反应蛋白。
- 同时评估人口学变量、合并症及包括最终转归在内的临床变量。
临床应用与阅片要点
- COVID-19患者D-二聚体升高常见且幅度可很大,不应据此替代超声评估决策。
- 阅片报告DVT时无需因COVID-19状态而改变诊断阈值或附加推测性结论。
局限性
- 回顾性病例对照设计,可能存在选择偏倚和信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Determine the rate of positive extremity ultrasound exams for DVT in patients with COVID-19 and assess for differences in laboratory values in patients with and without DVT, which could be used as a surrogate to decide the need for further evaluation with ultrasound.
METHODS: Retrospective case control study with 1:2 matching of cases (COVID-19+ patients) to controls (COVID-19- patients) based on age, gender, and race. Laboratory values assessed were serum D-dimer, fibrinogen, prothrombin time, international normalized ratio, and C-reactive protein. Demographic variables, comorbidities, and clinical variables including final disposition were also evaluated. P-values for categorical variables were calculated with the chi-square test or Fisher's exact test. P-values for continuous variables were compared with the use of a two-tailed unpaired t-test.
RESULTS: The rate of extremity ultrasound exams positive for DVT were similar in patients with (14.7%) and without (19.3%) COVID-19 (P = .423). No significant difference was observed in laboratory values including the D-dimer level in COVID-19 patients without (mean 9523.9 ng/mL (range 339 to >60,000)) or with DVT (mean 13,663.7 ng/mL (range 1193->60,000)) (P = .475). No differences were found in demographic variabilities or co-morbidities among COVID-19 patients with and without extremity DVT.
CONCLUSIONS: We found no statistically significant difference in rate of positive DVT studies between COVID-19+ and COVID-19- patients. D-dimer levels are elevated, in some cases markedly, in COVID-19 patients with and without DVTs and therefore these data do not support their use as a surrogate when assessing the need for ultrasound evaluation.
引用
- Bello HR, Heilbrun ME, Kallas ON, et al. Ultrasound Evaluation for Extremity Deep Vein Thrombus in COVID-19-Positive Patients: Exam Positivity Rate and Association With D-Dimer Level. J Ultrasound Med. 2021. PMID: 34562041. doi:10.1002/jum.15832
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。